• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Pediatrics

Revised autism screening tool (M-CHAT-R/F) may allow for earlier diagnosis

byLeah Carr, MD
December 24, 2013
in Pediatrics
Reading Time: 4 mins read
Severe maternal childhood abuse associated with autism in offspring
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. The Modified Checklist for Autism in Toddlers Revised with Follow-Up (M-CHAT-R/F) is an effective and reliable test for detecting autism spectrum disorder (ASD) that requires little time and cost to administer. 

2. The M-CHAT-R/F detected ASD at a significantly higher rate than the M-CHAT and allowed for ASD diagnosis by age 2, 2 years earlier than the median age of diagnosis of 4 years. 

Evidence Rating Level: 2 (Good)           

Study Rundown: Autism spectrum disorder (ASD) is characterized by communication and social interaction deficits along with restrictive and repetitive behaviors. As early intervention is known to improve long-term outcomes, the American Academy of Pediatrics (AAP) recommends autism-specific screenings at 18- and 24-month well-child care visits. One widely-used screening tool is a parent-report questionnaire called the Modified Checklist for Autism in Toddlers (M-CHAT). The current study sought to validate the revised version of the M-CHAT (M-CHAT-R) with a follow-up component, the M-CHAT Revised with Follow-Up (M-CHAT-R/F).Through this prospective study, the M-CHAT-R/F was determined to be a valid screening test, detecting ASD at a significantly higher rate than the M-CHAT and allowing for ASD diagnosis by age 2. There are several limitations to this study. First, it is possible that screen-negatives could have been missed at final diagnosis, therefore altering calculated “misses” and testing sensitivity. Also, some parents of children who initially screened positive did not complete the entire study course. Nevertheless, data from this study suggest that the M-CHAT-R/F is an effective and reliable screening tool for ASDs in a low-risk pediatric sample. Steps must be taken to ease its implementation at well-child visits.

Click to read the study published today in Pediatrics

RELATED REPORTS

American Cancer Society recommends regular PSA-based screening for men at average and higher risk

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Relevant Reading: Identification and Evaluation of Children with Autism Spectrum Disorders

Study Author, Dr. Diana L. Robins, PhD, talks to 2 Minute Medicine: Associate Professor of Psychology and Neuroscience, Georgia State University.

“Autism spectrum disorders (ASD) are severe developmental disorders. However, children who receive intensive early intervention have the best prognosis. Standardized ASD-specific screening can reduce the age of ASD detection by two years, compared to the national median age of diagnosis. The Modified Checklist for Autism in Toddlers, Revised, with Follow-Up (M-CHAT-R/F) is a 2-stage screening tool designed for use during toddler well-child care visits to pediatricians and other healthcare providers. Parents complete initial questions in about 5 minutes, and if results indicate ASD risk, parents complete the Follow-Up questions. Of children who continue to show ASD risk on the 2-stage M-CHAT-R/F, 95% are diagnosed with a developmental delay or concern about development, including ASD. This highlights the confidence physicians and healthcare providers have that referrals are needed when children screen positive on the 2-stage M-CHAT-R/F.”

In-Depth [prospective cohort study]: A total of 15 612 toddlers in metropolitan Atlanta or Conneticut were included in this study (mean age = 20.95 + 3.30 months, 7570 female). Of this group, 263 children screened positive for ASD and underwent a thorough diagnostic evaluation. First, parents completed the M-CHAT-R/F and those whose children screened positive were then contacted by telephone to complete the follow up, which consisted of structured questions with a clinician. Continued positive screens resulted in a full diagnostic evaluation. Across all M-CHAT-R items, internal consistency was below the threshold for adequate (*Cronbach’s α = .63), although when the 2-stage screen was examined, internal consistency was adequate (Cronbach’s α = .79). Of children with a total score on the screening tool of ≥3 initially and ≥2 at follow-up, 47.5% were diagnosed with ASD and 94.6% had some developmental delay or other concerns. Total score was more effective than alternative scores. The M-CHAT-R/F detected ASD at a significantly higher rate than the M-CHAT (67 cases per 10,000 using the M-CHAT-R/F vs. 45 cases per 10,000 using the M-CHAT; X2 = 8.63; P = .003) and allowed for ASD diagnosis by age 2.

*Cronbach’s α is a coefficient of internal consistency used to measure the reliability of a psychometric test. For example, an α value ≥ 0.9 could indicate “excellent” internal consistency, 0.7-0.9 is “good”, 0.6-0.7 is “acceptable”, 0.5-0.6 is “poor”, and α < 0.5 is “unacceptable.”

By Cordelia Y. Ross and Leah H. Carr

More from this author: AAP policy supports consumption of only pasteurized dairy products; Pregnancy and peripartum risk factors associated with childhood ADHD; Consistent parenting linked to lower child BMI; Cough medicine-related ED visits linked to unsupervised ingestion; Shared decision-making associated with increased parental resistance to vaccinations

©2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: autismautism spectrum disordersscreening
Previous Post

2 Minute Medicine Rewind December 16-22, 2013

Next Post

Peripregnancy nut consumption may decrease development of nut allergies

RelatedReports

Collage on the PSA blood test: an engraved bladder and prostate, a capped blood tube, a balance scale and a blank calendar
2MM Trial Briefs

American Cancer Society recommends regular PSA-based screening for men at average and higher risk

November 12, 2026
A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.
All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026
An illustration featuring a heart within a house, with a stethoscope, a scale, and medication, symbolizing heart failure home hospital care.
Artificial Intelligence

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

October 21, 2026
A middle-aged woman looks thoughtfully at an abstract representation of cells and a statin pill, symbolizing breast cancer and medication usage.
Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
Next Post

Peripregnancy nut consumption may decrease development of nut allergies

Classics Series, Landmark Trials in Medicine

PROS network study examines pubertal onset by race/ethnic groups [Pediatrics Classics Series]

Classics Series, Landmark Trials in Medicine

Low-lead exposure in childhood associated with worse cognitive performance [Pediatrics Classics Series]

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity
  • FDA accepted an application to review at-home use of dexmedetomidine for agitation in schizophrenia and bipolar disorder
  • In a randomized sham-controlled trial, acupoint thread embedding produced a between-group difference in change from baseline of 1.8 kg at 12 weeks and 3.0 kg at 24 weeks in Chinese women with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.